(Q39105368)

9 September 2017

MiR-148a regulates the growth and apoptosis in pancreatic cancer by targeting CCKBR and Bcl-2. (English)

1 reference

9 September 2017

1 reference

9

Li Li

1 reference

9 September 2017

Rui Zhang

1

1 reference

9 September 2017

Min Li

2

1 reference

9 September 2017

Wenqiao Zang

3

1 reference

9 September 2017

Xudong Chen

4

1 reference

9 September 2017

Yuanyuan Wang

5

1 reference

9 September 2017

Ping Li

6

1 reference

9 September 2017

Yuwen Du

7

1 reference

9 September 2017

Guoqiang Zhao

8

1 reference

9 September 2017

23 August 2013

1 reference

9 September 2017

1 reference

9 September 2017

35

1 reference

9 September 2017

1

1 reference

9 September 2017

837-844

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-013-1115-2

9 September 2017

0 references

cites work

Gastrin promotes human colon cancer cell growth via CCK-2 receptor-mediated cyclooxygenase-2 induction and prostaglandin E2 production

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

Enhanced expression of cholecystokinin-2 receptor promotes the progression of colon cancer through activation of focal adhesion kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

Gastrin and gastrin receptor activation: an early event in the adenoma-carcinoma sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

Review article: gastrin and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacter-induced gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

The CCK(2) receptor antagonist, YF476, inhibits Mastomys ECL cell hyperplasia and gastric carcinoid tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

Blocking gastrin and CCK-B autocrine loop affects cell proliferation and apoptosis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

Targeting gastrin for the treatment of gastric acid related disorders and pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

Cholecystokinin-2 receptor modulates cell adhesion through beta 1-integrin in human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

A single nucleotide polymorphism of the cholecystokinin-B receptor predicts risk for pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

Downregulation of the CCK-B receptor in pancreatic cancer cells blocks proliferation and promotes apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

Apoptosis and cancer: the genesis of a research field

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

Ribo-gnome: the big world of small RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

MicroRNAs in cell proliferation, cell death, and tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

MicroRNA-133 controls cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

Gastrin increases mcl-1 expression in type I gastric carcinoid tumors and a gastric epithelial cell line that expresses the CCK-2 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

Expression of cholecystokinin-2/gastrin receptor in the murine pancreas modulates cell adhesion and cell differentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

Expression of some tumor associated factors in human carcinogenesis and development of gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

Human colorectal cancers express a constitutively active cholecystokinin-B/gastrin receptor that stimulates cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

Expression of CCK2 receptors in the murine pancreas: proliferation, transdifferentiation of acinar cells, and neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

New approaches to therapy of cancers of the stomach, colon and pancreas based on peptide analogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

Blockade of cholecystokinin-2 receptor and cyclooxygenase-2 synergistically induces cell apoptosis, and inhibits the proliferation of human gastric cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

Nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-XL, (-)-Gossypol, enhances biological effect of genistein against BxPC-3 human pancreatic cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

The Bcl-2 apoptotic switch in cancer development and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

Bcl-w promotes gastric cancer cell invasion by inducing matrix metalloproteinase-2 expression via phosphoinositide 3-kinase, Akt, and Sp1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and invasion in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

Pharmacogenetics of anticancer drug sensitivity in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

Molecular prognostic markers in pancreatic cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1115-2

Antiserum raised against an epitope of the cholecystokinin B/gastrin receptor inhibits hepatic invasion of a human colon tumor

21 January 2018

1 reference

12 December 2020

Inactivating cholecystokinin-2 receptor inhibits progastrin-dependent colonic crypt fission, proliferation, and colorectal cancer in mice

1 reference

12 December 2020

Gastrin-induced apoptosis contributes to carcinogenesis in the stomach

1 reference

12 December 2020

CCK2 receptor expression transforms non-tumorigenic human NCM356 colonic epithelial cells into tumor forming cells

1 reference

12 December 2020

Targeting of cholecystokinin B/gastrin receptor in colonic, pancreatic and hepatocellular carcinoma cell lines

1 reference

12 December 2020

Bcl-2 expression correlates with lymphovascular invasion and long-term prognosis in breast cancer

1 reference

12 December 2020

Expression of the bcl-2 gene and its significance in human pancreatic carcinoma

1 reference

12 December 2020

10.1007/S13277-013-1115-2

Identifiers

DOI

1 reference

9 September 2017

1 reference